HEADER TRANSFERASE 19-OCT-16 5M4U TITLE ORTHORHOMBIC COMPLEX STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC TITLE 2 SUBUNIT (ISOFORM CK2ALPHA') WITH THE INHIBITOR 4'-CARBOXY-6,8-CHLORO- TITLE 3 FLAVONOL (FLC21) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA'; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA'; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A2, CK2A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE CK2, CASEIN KINASE 2, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.NIEFIND,N.BISCHOFF,S.M.YARMOLUK,V.G.BDZHOLA,A.G.GOLUB,A.O.BALANDA, AUTHOR 2 A.O.PRYKHOD'KO REVDAT 7 17-JAN-24 5M4U 1 REMARK REVDAT 6 10-OCT-18 5M4U 1 COMPND SOURCE REMARK DBREF REVDAT 6 2 1 SEQADV SEQRES HELIX SHEET REVDAT 6 3 1 SITE ATOM REVDAT 5 06-SEP-17 5M4U 1 REMARK REVDAT 4 17-MAY-17 5M4U 1 JRNL REVDAT 3 10-MAY-17 5M4U 1 JRNL REVDAT 2 25-JAN-17 5M4U 1 JRNL REVDAT 1 18-JAN-17 5M4U 0 JRNL AUTH K.NIEFIND,N.BISCHOFF,A.G.GOLUB,V.G.BDZHOLA,A.O.BALANDA, JRNL AUTH 2 A.O.PRYKHOD'KO,S.M.YARMOLUK JRNL TITL STRUCTURAL HYPERVARIABILITY OF THE TWO HUMAN PROTEIN KINASE JRNL TITL 2 CK2 CATALYTIC SUBUNIT PARALOGS REVEALED BY COMPLEX JRNL TITL 3 STRUCTURES WITH A FLAVONOL- AND A JRNL TITL 4 THIENO[2,3-D]PYRIMIDINE-BASED INHIBITOR. JRNL REF PHARMACEUTICALS V. 10 2017 JRNL REFN ESSN 1424-8247 JRNL PMID 28085026 JRNL DOI 10.3390/PH10010009 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.GUERRA,N.BISCHOFF,V.G.BDZHOLA,S.M.YARMOLUK,O.G.ISSINGER, REMARK 1 AUTH 2 A.G.GOLUB,K.NIEFIND REMARK 1 TITL A NOTE OF CAUTION ON THE ROLE OF HALOGEN BONDS FOR PROTEIN REMARK 1 TITL 2 KINASE/INHIBITOR RECOGNITION SUGGESTED BY HIGH- AND LOW-SALT REMARK 1 TITL 3 CK2ALPHA COMPLEX STRUCTURES. REMARK 1 REF ACS CHEM. BIOL. V. 10 1654 2015 REMARK 1 REFN ESSN 1554-8937 REMARK 1 PMID 25961323 REMARK 1 DOI 10.1021/ACSCHEMBIO.5B00235 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.G.GOLUB,V.G.BDZHOLA,N.V.BRIUKHOVETSKA,A.O.BALANDA, REMARK 1 AUTH 2 O.P.KUKHARENKO,I.M.KOTEY,O.V.OSTRYNSKA,S.M.YARMOLUK REMARK 1 TITL SYNTHESIS AND BIOLOGICAL EVALUATION OF SUBSTITUTED REMARK 1 TITL 2 (THIENO[2,3-D]PYRIMIDIN-4-YLTHIO)CARBOXYLIC ACIDS AS REMARK 1 TITL 3 INHIBITORS OF HUMAN PROTEIN KINASE CK2. REMARK 1 REF EUR J MED CHEM V. 46 870 2011 REMARK 1 REFN ISSN 1768-3254 REMARK 1 PMID 21276643 REMARK 1 DOI 10.1016/J.EJMECH.2010.12.025 REMARK 1 REFERENCE 3 REMARK 1 AUTH A.G.GOLUB,V.G.BDZHOLA,Y.V.KYSHENIA,V.M.SAPELKIN, REMARK 1 AUTH 2 A.O.PRYKHOD'KO,O.P.KUKHARENKO,O.V.OSTRYNSKA,S.M.YARMOLUK REMARK 1 TITL STRUCTURE-BASED DISCOVERY OF NOVEL FLAVONOL INHIBITORS OF REMARK 1 TITL 2 HUMAN PROTEIN KINASE CK2. REMARK 1 REF MOL. CELL. BIOCHEM. V. 356 107 2011 REMARK 1 REFN ISSN 1573-4919 REMARK 1 PMID 21735097 REMARK 1 DOI 10.1007/S11010-011-0945-8 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 28094 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.910 REMARK 3 FREE R VALUE TEST SET COUNT : 1142 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.5107 - 4.3893 1.00 3749 145 0.1692 0.1974 REMARK 3 2 4.3893 - 3.4844 1.00 3554 162 0.1362 0.1703 REMARK 3 3 3.4844 - 3.0440 1.00 3556 136 0.1530 0.1952 REMARK 3 4 3.0440 - 2.7658 1.00 3486 150 0.1732 0.2402 REMARK 3 5 2.7658 - 2.5675 1.00 3511 133 0.1802 0.2671 REMARK 3 6 2.5675 - 2.4162 1.00 3480 138 0.1785 0.2356 REMARK 3 7 2.4162 - 2.2952 1.00 3502 138 0.2043 0.2406 REMARK 3 8 2.2952 - 2.1953 0.94 3256 140 0.2639 0.2900 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.030 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.44 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2925 REMARK 3 ANGLE : 0.576 3943 REMARK 3 CHIRALITY : 0.043 402 REMARK 3 PLANARITY : 0.003 502 REMARK 3 DIHEDRAL : 15.776 1739 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 3 THROUGH 130 ) REMARK 3 ORIGIN FOR THE GROUP (A): 3.0720 -14.8249 -11.4226 REMARK 3 T TENSOR REMARK 3 T11: 0.1769 T22: 0.2237 REMARK 3 T33: 0.1653 T12: 0.0033 REMARK 3 T13: 0.0064 T23: 0.0158 REMARK 3 L TENSOR REMARK 3 L11: 1.1914 L22: 0.6533 REMARK 3 L33: 0.9669 L12: -0.2131 REMARK 3 L13: -0.2470 L23: 0.4476 REMARK 3 S TENSOR REMARK 3 S11: -0.0460 S12: -0.2706 S13: -0.0314 REMARK 3 S21: 0.1674 S22: 0.0302 S23: -0.0167 REMARK 3 S31: 0.0537 S32: 0.1107 S33: 0.0005 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 131 THROUGH 334 ) REMARK 3 ORIGIN FOR THE GROUP (A): 14.9445 -13.2497 -30.2894 REMARK 3 T TENSOR REMARK 3 T11: 0.1125 T22: 0.0986 REMARK 3 T33: 0.1013 T12: -0.0043 REMARK 3 T13: -0.0033 T23: 0.0057 REMARK 3 L TENSOR REMARK 3 L11: 1.3036 L22: 0.8480 REMARK 3 L33: 0.7755 L12: 0.1466 REMARK 3 L13: -0.0397 L23: 0.1086 REMARK 3 S TENSOR REMARK 3 S11: -0.0262 S12: 0.0663 S13: 0.0046 REMARK 3 S21: -0.0384 S22: 0.0365 S23: -0.0445 REMARK 3 S31: 0.0006 S32: -0.0207 S33: -0.0037 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5M4U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1200001933. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29246 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.195 REMARK 200 RESOLUTION RANGE LOW (A) : 44.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.19090 REMARK 200 R SYM (I) : 0.19090 REMARK 200 FOR THE DATA SET : 9.9900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 1.18500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.720 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3OFM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN STOCK SOLUTION: 5.5 MG/ML REMARK 280 CK2ALPHA'D39G-C336S IN 0.5 M NACL, 25 MM TRIS/HCL, PH 8.5; REMARK 280 INHIBITOR STOCK SOLUTION: 10 MM INHIBITOR IN DMSO; PROTEIN/ REMARK 280 INHIBITOR COMPLEX SOLUTION: 90 MICROLITER PROTEIN STOCK SOLUTION REMARK 280 + 10 MICROLITER INHIBITOR STOCK SOLUTION; RESERVOIR SOLUTION: 25 REMARK 280 % PEG5000 MME, 0.2 M AMMONIUM SULPHATE, 0.1 M MES BUFFER, PH 6.5; REMARK 280 DROP SOLUTION BEFORE EQULIBRATION: 0.3 MICROLITER PROTEIN/ REMARK 280 INHIBITOR COMPLEX SOLUTION + 0.3 MICROLITER RESERVOIR SOLUTION, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.42500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.17200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.89000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.17200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.42500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.89000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -13 REMARK 465 GLY A -12 REMARK 465 SER A -11 REMARK 465 SER A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 SER A -3 REMARK 465 GLN A -2 REMARK 465 ASP A -1 REMARK 465 PRO A 0 REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 PRO A 335 REMARK 465 SER A 336 REMARK 465 ALA A 337 REMARK 465 ASP A 338 REMARK 465 ASN A 339 REMARK 465 ALA A 340 REMARK 465 VAL A 341 REMARK 465 LEU A 342 REMARK 465 SER A 343 REMARK 465 SER A 344 REMARK 465 GLY A 345 REMARK 465 LEU A 346 REMARK 465 THR A 347 REMARK 465 ALA A 348 REMARK 465 ALA A 349 REMARK 465 ARG A 350 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 48 34.87 -141.89 REMARK 500 PRO A 73 95.05 -53.82 REMARK 500 ASP A 157 39.60 -153.96 REMARK 500 ASP A 176 80.45 56.43 REMARK 500 ALA A 194 -177.94 58.81 REMARK 500 MET A 209 53.28 -91.14 REMARK 500 ASP A 211 -157.50 -150.63 REMARK 500 HIS A 235 74.90 -105.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 813 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH A 814 DISTANCE = 7.63 ANGSTROMS REMARK 525 HOH A 815 DISTANCE = 8.80 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7FC A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 409 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 410 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 411 DBREF 5M4U A 1 350 UNP P19784 CSK22_HUMAN 1 350 SEQADV 5M4U MET A -13 UNP P19784 INITIATING METHIONINE SEQADV 5M4U GLY A -12 UNP P19784 EXPRESSION TAG SEQADV 5M4U SER A -11 UNP P19784 EXPRESSION TAG SEQADV 5M4U SER A -10 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -9 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -8 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -7 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -6 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -5 UNP P19784 EXPRESSION TAG SEQADV 5M4U HIS A -4 UNP P19784 EXPRESSION TAG SEQADV 5M4U SER A -3 UNP P19784 EXPRESSION TAG SEQADV 5M4U GLN A -2 UNP P19784 EXPRESSION TAG SEQADV 5M4U ASP A -1 UNP P19784 EXPRESSION TAG SEQADV 5M4U PRO A 0 UNP P19784 EXPRESSION TAG SEQADV 5M4U GLY A 39 UNP P19784 ASP 39 ENGINEERED MUTATION SEQADV 5M4U SER A 336 UNP P19784 CYS 336 ENGINEERED MUTATION SEQRES 1 A 364 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 A 364 PRO MET PRO GLY PRO ALA ALA GLY SER ARG ALA ARG VAL SEQRES 3 A 364 TYR ALA GLU VAL ASN SER LEU ARG SER ARG GLU TYR TRP SEQRES 4 A 364 ASP TYR GLU ALA HIS VAL PRO SER TRP GLY ASN GLN ASP SEQRES 5 A 364 GLY TYR GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SEQRES 6 A 364 SER GLU VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU SEQRES 7 A 364 ARG VAL VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS SEQRES 8 A 364 LYS ILE LYS ARG GLU VAL LYS ILE LEU GLU ASN LEU ARG SEQRES 9 A 364 GLY GLY THR ASN ILE ILE LYS LEU ILE ASP THR VAL LYS SEQRES 10 A 364 ASP PRO VAL SER LYS THR PRO ALA LEU VAL PHE GLU TYR SEQRES 11 A 364 ILE ASN ASN THR ASP PHE LYS GLN LEU TYR GLN ILE LEU SEQRES 12 A 364 THR ASP PHE ASP ILE ARG PHE TYR MET TYR GLU LEU LEU SEQRES 13 A 364 LYS ALA LEU ASP TYR CYS HIS SER LYS GLY ILE MET HIS SEQRES 14 A 364 ARG ASP VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLN SEQRES 15 A 364 GLN LYS LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU SEQRES 16 A 364 PHE TYR HIS PRO ALA GLN GLU TYR ASN VAL ARG VAL ALA SEQRES 17 A 364 SER ARG TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR SEQRES 18 A 364 GLN MET TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY SEQRES 19 A 364 CYS MET LEU ALA SER MET ILE PHE ARG ARG GLU PRO PHE SEQRES 20 A 364 PHE HIS GLY GLN ASP ASN TYR ASP GLN LEU VAL ARG ILE SEQRES 21 A 364 ALA LYS VAL LEU GLY THR GLU GLU LEU TYR GLY TYR LEU SEQRES 22 A 364 LYS LYS TYR HIS ILE ASP LEU ASP PRO HIS PHE ASN ASP SEQRES 23 A 364 ILE LEU GLY GLN HIS SER ARG LYS ARG TRP GLU ASN PHE SEQRES 24 A 364 ILE HIS SER GLU ASN ARG HIS LEU VAL SER PRO GLU ALA SEQRES 25 A 364 LEU ASP LEU LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SEQRES 26 A 364 GLN ARG LEU THR ALA LYS GLU ALA MET GLU HIS PRO TYR SEQRES 27 A 364 PHE TYR PRO VAL VAL LYS GLU GLN SER GLN PRO SER ALA SEQRES 28 A 364 ASP ASN ALA VAL LEU SER SER GLY LEU THR ALA ALA ARG HET 7FC A 401 23 HET GOL A 402 6 HET GOL A 403 6 HET GOL A 404 6 HET GOL A 405 6 HET GOL A 406 6 HET ACT A 407 4 HET ACT A 408 4 HET ACT A 409 4 HET CL A 410 1 HET SO4 A 411 5 HETNAM 7FC 4-[6,8-BIS(CHLORANYL)-3-OXIDANYL-4-OXIDANYLIDENE- HETNAM 2 7FC CHROMEN-2-YL]BENZOIC ACID HETNAM GOL GLYCEROL HETNAM ACT ACETATE ION HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 7FC C16 H8 CL2 O5 FORMUL 3 GOL 5(C3 H8 O3) FORMUL 8 ACT 3(C2 H3 O2 1-) FORMUL 11 CL CL 1- FORMUL 12 SO4 O4 S 2- FORMUL 13 HOH *315(H2 O) HELIX 1 AA1 SER A 21 ASP A 26 1 6 HELIX 2 AA2 TYR A 27 HIS A 30 5 4 HELIX 3 AA3 LYS A 75 ARG A 90 1 16 HELIX 4 AA4 ASP A 121 GLN A 127 1 7 HELIX 5 AA5 THR A 130 LYS A 151 1 22 HELIX 6 AA6 LYS A 159 HIS A 161 5 3 HELIX 7 AA7 SER A 195 LYS A 199 5 5 HELIX 8 AA8 GLY A 200 VAL A 205 1 6 HELIX 9 AA9 TYR A 212 ARG A 229 1 18 HELIX 10 AB1 ASP A 238 GLY A 251 1 14 HELIX 11 AB2 GLY A 251 TYR A 262 1 12 HELIX 12 AB3 ASP A 267 ILE A 273 5 7 HELIX 13 AB4 ARG A 281 ILE A 286 5 6 HELIX 14 AB5 ASN A 290 VAL A 294 5 5 HELIX 15 AB6 SER A 295 LEU A 306 1 12 HELIX 16 AB7 THR A 315 GLU A 321 1 7 HELIX 17 AB8 HIS A 322 VAL A 329 5 8 SHEET 1 AA1 6 GLY A 35 ASN A 36 0 SHEET 2 AA1 6 LEU A 98 LYS A 103 1 O THR A 101 N GLY A 35 SHEET 3 AA1 6 PRO A 110 GLU A 115 -1 O VAL A 113 N ILE A 99 SHEET 4 AA1 6 ARG A 65 ILE A 70 -1 N VAL A 67 O PHE A 114 SHEET 5 AA1 6 GLU A 53 ASN A 59 -1 N PHE A 55 O VAL A 68 SHEET 6 AA1 6 TYR A 40 LEU A 46 -1 N VAL A 43 O GLU A 56 SHEET 1 AA2 2 ILE A 153 MET A 154 0 SHEET 2 AA2 2 GLU A 181 PHE A 182 -1 O GLU A 181 N MET A 154 SHEET 1 AA3 2 VAL A 163 ASP A 166 0 SHEET 2 AA3 2 LYS A 171 LEU A 174 -1 O LYS A 171 N ASP A 166 CISPEP 1 GLU A 231 PRO A 232 0 -8.58 SITE 1 AC1 13 ARG A 48 VAL A 67 LYS A 69 ILE A 96 SITE 2 AC1 13 PHE A 114 GLU A 115 TYR A 116 ILE A 117 SITE 3 AC1 13 MET A 164 ILE A 175 ASP A 176 HOH A 542 SITE 4 AC1 13 HOH A 646 SITE 1 AC2 4 TRP A 34 LYS A 80 LYS A 103 HOH A 717 SITE 1 AC3 4 ARG A 9 ALA A 10 ALA A 14 HOH A 501 SITE 1 AC4 5 TRP A 25 HIS A 184 GLN A 187 ACT A 408 SITE 2 AC4 5 HOH A 527 SITE 1 AC5 6 HIS A 277 SER A 278 LYS A 280 HOH A 505 SITE 2 AC5 6 HOH A 536 HOH A 553 SITE 1 AC6 7 PHE A 122 LYS A 123 HIS A 161 GLU A 231 SITE 2 AC6 7 HOH A 651 HOH A 672 HOH A 682 SITE 1 AC7 4 GLU A 15 SER A 18 LEU A 19 ASN A 284 SITE 1 AC8 4 ASP A 26 TYR A 27 GLU A 28 GOL A 404 SITE 1 AC9 2 ARG A 192 LYS A 199 SITE 1 AD1 2 GLU A 87 ARG A 90 SITE 1 AD2 6 ARG A 81 ARG A 156 ASN A 190 HOH A 552 SITE 2 AD2 6 HOH A 628 HOH A 657 CRYST1 46.850 83.780 142.344 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021345 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011936 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007025 0.00000